Clinical trial
A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone
NCT03738215 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone
- Lead sponsor
- AbbVie
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 9, 2018
- Completion date
- September 30, 2021
- Enrollment
- 759 (actual)
- Sites
- 125
Conditions
As the registry lists them; a condition with its own page is linked.